On March 6, 4:30-5:30PM, Boston Children’s Hospital will host a talk, Breakthroughs in Genetic Medicine: RNAi Therapeutics from Bench to Bedside to Approval, presented by Kevin Fitzgerald, who directs research and translational science at Alnylam Pharmaceuticals in Cambridge. Registration is free for this event in Folkman Auditorium, Enders Building, Boston Children’s Hospital, 320 Longwood Avenue, Boston.